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The cDNA for vitamin D 25-hydroxylase in rat liver mitochondria was transfected in COS cells in order to confirm our previous postulation that 
both 5fl-cholestane-3ct,7ct,12~-triol 27-hydroxylation a d vitamin D 25-hydroxylation are catalyzed by a common enzyme. As a result it was found 
that both enzyme activities could be reconstituted from the solubilized extract of mitochondria ofthese cells, NADPH, NADPH-adrenodoxin reduc- 
tase and adrenodoxin, giving unequivocal evidence that the two enzyme activities are catalyzed by a common enzyme. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Through more than 20 years of research we have 
established that the P450 that hydroxylates 5/3- 
cholestane-3a,7a-diol and 5/3-cholestane-3c~,7a,12c~- 
triol, which are the intermediates in the conversion of 
cholesterol to bile acids, at position 27 [1-12] does exist 
in liver mitochondria. Meanwhile, Bj6rkhem and 
Holmberg found an activity catalyzing vitamin D3 
25-hydroxylation i  liver mitochondria, an important 
reaction which should be carried out before vitamin D3 
is converted into its active form, la,25-dihydroxyvita- 
min D3 [13,14]. Since then a question has arisen 
whether these two P450s are identical or not. Recently, 
we have purified both enzymes to a homogeneity based 
on their catalytic activities [12,15]. To our surprise, 
both preparations revealed the enzyme activity of the 
other [16]. Since vitamin D 25-hydroxylation and 
cholestanetriol 27-hydroxylation are esentially different 
reactions, we considered at first that it was due to a con- 
tamination of the other enzyme. However, further 
studies based on enzyme kinetics as well as 
chromatographic properties led us to postulate that the 
two enzyme activities are catalyzed by a common active 
site of a common enzyme protein [16,17]. 
For further confirmation of this postulation we 
isolated a cDNA for liver mitochondrial P450 using the 
polyclonal antibodies against the nzyme purified by 
vitamin D 25-hydroxylation activity [18] and expressed 
the cDNA in COS cells to test whether mitochondria of 
the transfected cells can catalyze both enzyme activities. 
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5/3-[3H]Cholestane-3a,7o~,12a-triol was synthesized as described 
elsewhere [12] and lu-hydroxyvitamin D3 was purchased from 
Duphar BV (Weesp, The Netherlands). Adrenodoxin and NADPH- 
adrenodoxin reductase were prepared according to the method of 
Suhara et al. [19,20]. The cDNA (1.9 kbp) for vitamin D 
25-hydroxylase was obtained as described ina previous paper [18] and 
was ligated into the expression vector pSVL in Smal site (designated 
as pSVL25). Simian COS 7 cells were transfected by the DEAE- 
dextran method [21]. To assay the activity of both cholestanetriol 
27-hydroxylase and vitamin D 25-hydroxylase in vitro, cells were 
harvested 72 h after transfection, frozen at - 80°C and then thawed 
to homogenize them with an equal volume of 0.25 M sucrose buffer 
(pH 7.4). Mitochondria were obtained by differential centrifugation 
and solubilized by 10°70 cholate. Reconstitution of the enzyme ac- 
tivities was performed as described previously, using NADPH, 
adrenodoxin and NADPH-adrenodoxin reductase as electron donors 
[12,15]. The solubilized mitochondrial extract was incubated with 5/3- 
[3H]cholestane-3~,7a,12~-triol or la-hydroxyvitamin D3 (a deriva- 
tive of vitamin D~ synthesized for therapeutic use for vitamin D defi- 
ciency and is the preferred substrate for vitamin D 25-hydroxylase to 
vitamin D3 since the turnover number toward the former is 8-10-fold 
higher than toward the latter). The product of the former was con- 
firmed by thin layer chromatography [12]. The product of the latter 
was analyzed by both straight and reversed phase high performance 
liquid chromatographies (HPLC) as described previously [15]. For 
further identification of the product another straight phase solvent 
system (dichloromethane/propanol, 2:19) was also used to differen- 
tiate the product from a possible peroxidation byproduct, 10-oxo-19- 
nor-25-hydroxyvitamin D3 [22]. Western blotting was performed by 
the method of Towbin et al. [23]. 
3. RESULTS AND DISCUSSION 
The results are as shown in Table I. The solubilized 
mitochondrial fraction of pSVL25-transfected cells 
revealed both 5~-cholestane-3a,7c~,12c~-triol 27-hy- 
droxylation and vitamin D 25-hydroxylation activities. 
The mitochondrial fraction obtained from control ceils 
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Table I 
Expression of 5~-cholestane-3u,7a,12c~-triol 27-hydroxylase and vitamin D 25-hydroxylase in COS 7 cells 
November 1990 
Exp. 5~-Cholestane-3u,7a,12ct,27-tetrol la,25-Dihidroxy-vitamin D3 Ratio of the two enzyme activities 
no. formed (A) formed a (B) (A/B) 
(pmol/min/mg of protein) (pmol/min/mg of protein) 
1 pSVL25-COS 114 2.33 49 
Control-COS 6.7 0.17 39 
2 pSVL25-COS 80.2 1.68 48 
Control-COS 7.9 0.21 38 
Mitochondrial fraction was prepared from COS cells 72 h after transfecting the recombinant (pSVL25) or non-recombinant (control) expression 
vector. Reconstitution mixture contained solubilized mitochondria, NADPH-adrenodoxin reductase, adrenodoxin and NADPH and either 
substrate. 
avitamin D 25-hydroxylase activity was assayed using la-hydroxy vitamin D3 as substrate 
transfected with only pSVL vector produced more than 
10-fold lower amounts of products. The product of ls- 
hydroxyvitamin D3showed the same retention time as 
that of the authentic sample both on straight and revers- 
ed phase high performance liquid chromatographies 
and the product of cholestanetriol showed the same Rf 
value as that of 5~-cholestane-3a,7u,12ct,27-tetrol on 
thin layer chromatography. The ratio of the two hy- 
droxylation activities was similar to those observed with 
rat liver mitochondria and the purified enzyme [17]. 
Western blotting analysis of the expressed protein in the 
transfected cells (Fig. 1, lane 2) showed that a single 
protein band (Mr 52 500) reactive with anti-vitamin D
25-hydroxylase antibodies was observable at the posi- 
tion corresponding to the purified vitamin D 25-hy- 
droxylase (lane 3), whereas in control cells no such im- 
munoreactive band was observable (lane 1). Since no 
other band reacting with the antibodies was observed, 
the expressed protein seemed to have been wel process- 
ed to be converted into the mature form. 
During the course of our study, Dahlb~ick and 
Wikvall [24] purified rabbit liver mitochondrial P450 
based on absorption spectra and noticed that the 
preparation revealed 5~-cholestanetriol 26 (or 27)- 
! 2 3 
Fig. 1. Western blotting of the protein expressed in COS cells 
transfected with pSVL25. Mitochondrial proteins were subjected to 
the SDS-polyacrylamide g l electrophoresis and first incubated with 
the antibodies to rat liver mitochondrial vitamin D 25-hydroxylase 
and then visualized by incubating with 1251-anti-mouse antibodies. 
Lane 1, control cells transfected with only pSVL vector (42 #g); Lane 
2, transfected cells (42 #g); Lane 3, the purified rat liver mitochondrial 
vitamin D 25-hydroxylase (1.3 #g). 
hydroxylation activity together with very low vitamin 
D3 25-hydroxylation activity. Since the turnover 
number of rabbit liver mitochondrial vitamin D3 
25-hydroxylase was unknown and the vitamin D3 
25-hydroxylation activity was very low, it was not possi- 
ble to establish whether it was due to contamination by
vitamin D3 25-hydroxylase or not. Subsequently, 
Andersson et al. [25] isolated a cDNA encoding rabbit 
liver mitochondrial cholestanetriol 26(or 27)-hydroxy- 
lase and expressed it in COS cells. However, nothing is 
described about he vitamin D3 25-hydroxylation activi- 
ty of the expressed protein. Meanwhile, Dahlb~ick [26] 
observed that a monoclonal antibody raised against 
cholestanetriol 26(or 27)-hydroxylase was able to bind 
only cholestanetriol 26 (or 27)-hydroxylase and to 
decrease the activity of 26 (or 27)-hydroxylation f 5B- 
cholestane-3a,7et,12ct-triol, whereas it did not decrease 
vitamin D3 25-hydroxylation activity. She thus sug- 
gested that different species of liver mitochondrial 
P450s are involved in the two hydroxylations. The 
reason of the discrepancy is presently unknown. 
In conclusion, we have now obtained unequivocal 
evidence that a single protein expressed from a single 
cDNA for vitamin D 25-hydroxylase reveals the two en- 
zyme activities, vitamin D3 25-hydroxylation a d 5B- 
cholestane-3ct,7ct,12a-triol 27-hydroxylation. Since 
these two reactions are functionally different, this may 
provide an example of broad functional specificity of 
cytochrome P450. This may be an additional versatility 
of cytochrome P450, which is already well-known for 
its versatility of showing broad substrate specificity and 
broad regio-selectivity. 
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